CompletedPhase 2NCT00131911

Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors

Studying Zollinger-Ellison syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Cancer Institute (NCI)
Principal Investigator
Timothy Hobday, M.D
Mayo Clinic
Intervention
sorafenib tosylate(drug)
Enrollment
93 enrolled
Eligibility
18 years · All sexes
Timeline
2005 – 2013

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00131911 on ClinicalTrials.gov

Other trials for Zollinger-Ellison syndrome

Additional recruiting or active studies for the same condition.

See all trials for Zollinger-Ellison syndrome →

← Back to all trials